ASTEC — Astec LifeSciences Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹15.84bn
- IN₹20.20bn
- IN₹4.48bn
Annual cashflow statement for Astec LifeSciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 1,211 | 349 | -617 | -1,410 | -810 |
| Depreciation | |||||
| Non-Cash Items | 73.7 | 169 | 272 | 574 | 339 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1,393 | -108 | 85.3 | 315 | -785 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 236 | 747 | 102 | -84 | -807 |
| Capital Expenditures | -1,040 | -1,173 | -1,355 | -218 | -55.4 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 1.12 | 47.5 | 3.17 | 65.9 | 12.3 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1,039 | -1,125 | -1,352 | -152 | -43.1 |
| Financing Cash Flow Items | -89.1 | -201 | 268 | -396 | -816 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 805 | 378 | 1,250 | 237 | 945 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2.16 | -0.811 | -0.019 | 1.04 | 94.7 |